soul trial oral semaglutide cardiovascular outcomes 2024 2025

soul trial oral semaglutide cardiovascular outcomes 2024 2025 Frontiers Frontiers | Cardiovascular Safety and

Name: soul trial oral semaglutide cardiovascular outcomes 2024 2025 Frontiers Frontiers | Cardiovascular Safety and
Brand: jpsce.com.my
SKU: 517814555
Price: 27.11 USD
Availability: InStock
Rating: 4.2547 (24 reviews)

SKU: 517814555

4.3

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

doi: 10.1016/j.nut.2022.111807 15

Intestine-specific gene transfer experiments of pancreatic and duodenal homeobox-1 ( Pdx1 ) siRNA in 810-week-old mice reveal that posteriori suppression of Pdx1 decreases K-cell number, intestinal GIP protein and mRNA expression, and GIP secretion in response to an oral glucose tolerance test (OGTT) (Ikeguchi et al., 2018)